Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neurofibromatosis 1 1Attention Deficit Disorder with Hyperactivity 1

Interventions

Specimen Handling 69Magnetic Resonance Spectroscopy 52Biopsy 42Carboplatin 25pembrolizumab 23Radiation 23Cyclophosphamide 23Radiotherapy 22Cisplatin 20Paclitaxel 19Nivolumab 19Etoposide 18olaparib 17Doxorubicin 17X-Rays 16Vincristine 16Immunoglobulin G 15Disulfides 15Taxes 14Leucovorin 14Dexamethasone 14Cytarabine 14Prednisone 13Platinum 13Bevacizumab 131,2-diaminocyclohexaneplatinum II citrate 13durvalumab 12Radiotherapy, Intensity-Modulated 12Methotrexate 11Ipilimumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Acetylcysteine × 30 days × Clear all
NCT04481048 2026-06-05

DoDNAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
25 enrolled 12 charts
CNS

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡